Skip to main content

Paired Ends: Oct 4, 2011

Premium

Michael Glynn has been appointed to chief commercial officer at Pacific Biosciences. He joins PacBio from Genzyme, where he served as the regional president of Japan and Asia Pacific, and also as a senior vice president.

Previously, he spent seven years at Boston Scientific, most recently as president of its Endovations division in the US. He also held various roles at Memtec, Baxter International, Burroughs Wellcome, Estee Lauder, and Elizabeth Arden.

He holds an MBA from Macquarie University in Sydney and a BS from the National University of Ireland.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.